Louisa Hector

Analyst

Berenberg

Equibles does not estimate personal net worth.

About Louisa Hector

Louisa Hector is recorded as Analyst at Berenberg. Louisa Hector has spoken on 2 earnings calls and 1 other investor event across 3 companies, most recently for Regeneron Pharmaceuticals, Inc. on October 1, 2026. Those appearances were for Regeneron Pharmaceuticals, Inc. (REGN), Roche Holding AG and AbbVie Inc. (ABBV). The companies whose calls Louisa Hector spoke on are classified in the Healthcare sector.

Louisa Hector on recent calls

“My question is really on the sort of overlap in the mechanisms versus Dupixent and whether you considered other mechanisms, perhaps any thoughts on tri-specifics and whether there was any attempt to add external assets as you were renegotiating or is this essentially you're tied to the original mechanism from DIPI and…”

Analyst — Berenberg, Regeneron & Sanofi Investor Event · October 1, 2026

“So I just wanted to check, are you expecting an advisory committee meeting for Jira Destrant? And then you highlighted your excellent 80% phase three success rate year to date.”

Analyst — Berenberg, Roche’s Half-Year Results 2026 Presentation · July 23, 2026

“On aesthetics, just to check, are there any regions where you are losing share in toxins or fillers? And is this franchise less profitable than when you acquired it?”

Analyst — Berenberg, AbbVie Inc. Q4 FY2025 Earnings Call · February 4, 2026